Jaume Mora

28PUBLICATIONS
238CO-AUTHORS
Nanotoxicology, health and safetyCancer diagnosisMolecular targetsEnvironmental epidemiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 04, 2026
Quantum-Capacitance Biosensing Enables Real-Time Monitoring of Naxitamab for Therapeutic Response Stratification in Neuroblastoma.

|Apr 05, 2026
Scaling-Up Research in Childhood Cancer in Low- and Middle-Income Countries.

Jaume Mora, Scott Howard, Daniel C Moreira

|Nov 06, 2025
PRKG1 hinders myogenic differentiation and predicts response to AKT inhibitor ipatasertib in Rhabdomyosarcoma.

Estela Prada, Pablo Táboas, Evelyn Andrades

|Oct 24, 2025
EWS::FLI1 expression in human embryonic mesenchymal stem cells leads to transcriptional reprograming, defective DNA damage repair and Ewing sarcoma.

Inmaculada Hernández-Muñoz, Irene Cuervas, Estela Prada

|Oct 14, 2025
KDM6 Demethylases Contribute to EWSR1::FLI1-Driven Oncogenic Reprogramming in Ewing Sarcoma.

Elisabet Figuerola-Bou, Carla Ríos-Astorch, Enrique Blanco

|Sep 05, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

Pageof 5

Frequent Collaborators

5 joint publications

Angel M Carcaboso

3 joint publications

Elisabet Figuerola-Bou

3 joint publications

Katia Scotlandi

3 joint publications

Cinzia Lavarino